Editor: NOEL GONZÁLEZ GOTERA Número 122 Diseño: Lic. Roberto Chávez y Liuder Machado. Semana 080214– 140214 Fotos: Lic. Belkis Romeu e Instituto Finlay La Habana, Cuba.
ARTÍCULOS CIENTÍFICOS
Publicaciones incluidas en PubMED durante el período comprendido entre el 7 y el 14 de febrero de 2014. Con “vaccin*” en título: 119 artículos recuperados.
Vacunas Meningococo (Neisseria meningitidis)
108. Review of meningococcal vaccines with updates on immunization in adults.
Zahlanie YC, Hammadi MM, Ghanem ST, Dbaibo GS.
Hum Vaccin Immunother. 2014 Feb 5;10(4). [Epub ahead of print] Review.
PMID: 24500529 [PubMed - as supplied by publisher]
Related citations
Select item 24500396
Vacunas BCG – ONCO BCG (Mycobacterium bovis)
104. Pulmonary BCG vaccination confers dose-dependent superior protection than subcutaneous vaccination.
Aguilo N, Toledo AM, Lopez-Roman EM, Perez-Herran E, Gormley E, Rullas-Trincado J, Angulo- Barturen I, Martin C.
Clin Vaccine Immunol. 2014 Feb 5. [Epub ahead of print]
PMID: 24501340 [PubMed - as supplied by publisher]
Related citations
Select item 24501164
1
Vacunas Neumococo (Streptococcus pneumoniae)
68. Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumonia.
Rodrigo C, Bewick T, Sheppard C, Greenwood S, Trotter C, Slack M, George R, Lim WS.
Vaccine. 2014 Feb 6. pii: S0264-410X(14)00067-X. doi: 10.1016/j.vaccine.2014.01.035. [Epub ahead of print]
PMID: 24508039 [PubMed - as supplied by publisher]
Related citations
Select item 24508037
76. Modeling the impact of the 7-valent pneumococcal conjugate vaccine in Chinese infants: an economic analysis of a compulsory vaccination.
Che D, Zhou H, He J, Wu B.
BMC Health Serv Res. 2014 Feb 7;14(1):56. [Epub ahead of print]
PMID: 24507480 [PubMed - as supplied by publisher] Free PMC Article
Related citations
Select item 24507384
92. Costs of vaccine delivery in the Gambia before and after, pentavalent and pneumococcal conjugate vaccine introductions.
Usuf E, Mackenzie G, Lowe-Jallow Y, Boye B, Atherly D, Suraratdecha C, Griffiths UK.
Vaccine. 2014 Feb 3. pii: S0264-410X(14)00082-6. doi: 10.1016/j.vaccine.2014.01.045. [Epub ahead of print]
PMID: 24503271 [PubMed - as supplied by publisher]
Related citations
Select item 24503087
99. Immune response in nasopharynx, lung, and blood elicited by experimental nasal pneumococcal vaccines containing live or heat-killed lactobacilli as mucosal adjuvants.
Vintiñi EO, Medina M.
Can J Physiol Pharmacol. 2014 Feb;92(2):124-31. doi: 10.1139/cjpp-2013-0227. Epub 2014 Jan 30.
2
PMID: 24502635 [PubMed - in process]
Related citations
Select item 24501540
119. Incidence of pediatric invasive pneumococcal disease in the Island of Majorca (2008- 2010), an area with non-universal vaccination, and estimations of serotype & children population coverage by available conjugate vaccines.
Picazo J, Dueñas J, Ramirez A, Perez AR, Padilla E, Herrero S, Gallegos C, Culebras E, Balseiro C, Mendez C.
BMC Infect Dis. 2013 Oct 29;13:503. doi: 10.1186/1471-2334-13-503.
PMID: 24498901 [PubMed - in process] Free PMC Article
Related citations
Vacuna Tosferina (Bordetella pertussis)
24. Epidemiological evidence for herd immunity induced by acellular pertussis vaccines.
Domenech de Cellès M, Riolo MA, Magpantay FM, Rohani P, King AA.
Proc Natl Acad Sci U S A. 2014 Feb 10. [Epub ahead of print] No abstract available.
PMID: 24516173 [PubMed - as supplied by publisher]
Related citations
Select item 24515514
25. Duration of Protection After First Dose of Acellular Pertussis Vaccine in Infants.
Quinn HE, Snelling TL, Macartney KK, McIntyre PB.
Pediatrics. 2014 Feb 10. [Epub ahead of print]
PMID: 24515514 [PubMed - as supplied by publisher]
Related citations
Select item 24515506
Vacuna Tuberculosis (Mycobacterium tuberculosis)
118. Construction and Immunogenicity of the DNA Vaccine of Mycobacterium Tuberculosis dormancy antigen Rv1733c.
Zhang W, Jiang H, Bai YL, Kang J, Xu ZK, Wang LM. 3
Scand J Immunol. 2014 Feb 5. doi: 10.1111/sji.12160. [Epub ahead of print]
PMID: 24498941 [PubMed - as supplied by publisher]
Related citations
Select item 24498901
Vacunas Tiomersal (como preservante)
110. Chile votes to ban thiomersal in vaccines despite opposition from doctors and scientists.
Arie S.
BMJ. 2014 Feb 5;348:g1355. doi: 10.1136/bmj.g1355. No abstract available.
PMID: 24500362 [PubMed - in process]
Related citations
Select item 24500288
Vacunas Cólera (Vibrio cholerae)
20. Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide.
Alam MM, Bufano MK, Xu P, Kalsy A, Yu Y, Freeman YW, Sultana T, Rashu MR, Desai I, Eckhoff G, Leung DT, Charles RC, Larocque RC, Harris JB, Clements JD, Calderwood SB, Qadri F, Vann WF, Kováč P, Ryan ET.
PLoS Negl Trop Dis. 2014 Feb 6;8(2):e2683. doi: 10.1371/journal.pntd.0002683. eCollection 2014 Feb.
PMID: 24516685 [PubMed - in process] Free Article
Related citations
Select item 24516675
21. Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the odisha model.
Kar SK, Sah B, Patnaik B, Kim YH, Kerketta AS, Shin S, Rath SB, Ali M, Mogasale V, Khuntia HK, Bhattachan A, You YA, Puri MK, Lopez AL, Maskery B, Nair GB, Clemens JD, Wierzba TF.
PLoS Negl Trop Dis. 2014 Feb 6;8(2):e2629. doi: 10.1371/journal.pntd.0002629. eCollection 2014 Feb.
PMID: 24516675 [PubMed - in process] Free Article
4
Related citations
Select item 24516595
22. Methods to Assess the Impact of Mass Oral Cholera Vaccination Campaigns under Real Field Conditions.
Deen J, Ali M, Sack D.
PLoS One. 2014 Feb 7;9(2):e88139. doi: 10.1371/journal.pone.0088139. eCollection 2014.
PMID: 24516595 [PubMed - in process] Free Article
Related citations
Select item 24516377
84. Construction and Evaluation of V. cholerae O139 Mutant, VCUSM21P, as a Safe Live Attenuated Cholera Vaccine.
Murugaiah C, Nik Mohd Noor NZ, Mustafa S, Manickam R, Pattabhiraman L.
PLoS One. 2014 Feb 5;9(2):e81817. doi: 10.1371/journal.pone.0081817. eCollection 2014.
PMID: 24505241 [PubMed - in process] Free PMC Article
Related citations
Select item 24504509
Vacunas, otras
1. Hemodialysis and hepatitis B vaccination: a challenge to physicians.
Ayub MA, Bacci MR, Fonseca FL, Chehter EZ.
Int J Gen Med. 2014 Feb 3;7:109-14. doi: 10.2147/IJGM.S57254. eCollection 2014.
PMID: 24520201 [PubMed]
Related citations
Select item 24520126 2.
Vaccine-Associated Paralytic Poliomyelitis in the Postelimination Era in Latin America and the Caribbean, 1992-2011.
5
Landaverde JM, Trumbo SP, Danovaro-Holliday MC, Cochi SE, Gandhi R, Ruiz-Matus C.
J Infect Dis. 2014 Feb 11. [Epub ahead of print]
PMID: 24520126 [PubMed - as supplied by publisher]
Related citations
Select item 24520125 3.
Combination therapy with an anti-IL-1β antibody and GAD65 DNA vaccine can reverse recent-onset diabetes in the RIP-GP mouse model.
Pagni PP, Bresson D, Rodriguez-Calvo T, Hani AB, Manenkova Y, Amirian N, Blaszczak A, Faton S, Sachithanantham S, von Herrath MG.
Diabetes. 2014 Feb 11. [Epub ahead of print]
PMID: 24520125 [PubMed - as supplied by publisher]
Related citations
Select item 24520094 4.
Phase I Trial of a Bivalent Gangliosides Vaccine in Combination with β-Glucan for High- Risk Neuroblastoma in Second or Later Remission.
Kushner BH, Cheung IY, Modak S, Kramer K, Ragupathi G, Cheung NK.
Clin Cancer Res. 2014 Feb 11. [Epub ahead of print]
PMID: 24520094 [PubMed - as supplied by publisher]
Related citations
Select item 24520093 5.
Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly- ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells.
Rapoport AP, Aqui NA, Stadtmauer EA, Vogl DT, Xu YY, Kalos M, Cai L, Fang HB, Weiss BM, Badros A, Yanovich S, Akpek G, Tsao P, Cross A, Mann D, Philip S, Kerr N, Brennan A, Zheng Z, Ruehle K, Milliron T, Strome SE, Salazar AM, Levine BL, June CH.
6
Clin Cancer Res. 2014 Feb 11. [Epub ahead of print]
PMID: 24520093 [PubMed - as supplied by publisher]
Related citations
Select item 24520078 6.
Vaccine-Mediated Immunotherapy Directed Against a Transcription Factor Driving the Metastatic Process.
Ardiani A, Gameiro SR, Palena C, Hamilton D, Kwilas A, King TH, Schlom J, Hodge JW.
Cancer Res. 2014 Feb 11. [Epub ahead of print]
PMID: 24520078 [PubMed - as supplied by publisher]
Related citations
Select item 24519777 7.
[Is vaccination against varicella efficacious and how long does the protection last?]
Ołdak E.
Med Wieku Rozwoj. 2013;17(4):341-346. Polish.
PMID: 24519777 [PubMed - as supplied by publisher]
Related citations
Select item 24519704 8.
[Vaccinations for international travelers.]
Berens-Riha N, Alberer M, Löscher T.
Internist (Berl). 2014 Feb 13. [Epub ahead of print] German.
PMID: 24519704 [PubMed - as supplied by publisher]
Related citations
7
Select item 24519299 9.
Association of varying number of doses of quadrivalent human papillomavirus vaccine with incidence of condyloma.
Herweijer E, Leval A, Ploner A, Eloranta S, Simard JF, Dillner J, Netterlid E, Sparén P, Arnheim-Dahlström L.
JAMA. 2014 Feb 12;311(6):597-603. doi: 10.1001/jama.2014.95.
PMID: 24519299 [PubMed - in process]
Related citations
Select item 24518843 10.
[Reported adverse events following influenza vaccination]. van Balveren-Slingerland L, Rümke HC, Kant AC.
Ned Tijdschr Geneeskd. 2014;158(0):A6841. Dutch.
PMID: 24518843 [PubMed - in process]
Related citations
Select item 24518799 11.
The Appropriate Use of Vaccines in Patients With Inflammatory Bowel Disease.
Lodhia N.
J Clin Gastroenterol. 2014 Feb 10. [Epub ahead of print]
PMID: 24518799 [PubMed - as supplied by publisher]
Related citations
Select item 24518685 12.
PEG-pHPMAm-based polymeric micelles loaded with doxorubicin-prodrugs in combination antitumor therapy with oncolytic vaccinia viruses.
8
Ruiz-Hernández E, Hess M, Melen GJ, Theek B, Talelli M, Shi Y, Ozbakir B, Teunissen EA, Ramírez M, Moeckel D, Kiessling F, Storm G, Scheeren HW, Hennink WE, Szalay AA, Stritzker J, Lammers T.
Polym Chem. 2014 Mar 7;(5):1674-1681.
PMID: 24518685 [PubMed]
Related citations
Select item 24518554 13.
Reply to Shin and Bayry on "An age-related decline of CD62L and vaccine response: a role of microRNA 92a?"
Vorup-Jensen T, Rosenberg C, Petersen E.
Hum Vaccin Immunother. 2014 Feb 11;10(5). [Epub ahead of print]
PMID: 24518554 [PubMed - as supplied by publisher]
Related citations
Select item 24518355 14.
Ethical Issues With Vaccination for the Obstetrician-Gynecologist.
Riley LE, Minkoff H.
Obstet Gynecol. 2014 Feb 10. [Epub ahead of print] No abstract available.
PMID: 24518355 [PubMed - as supplied by publisher]
Related citations
Select item 24517667 15.
Increased risk of sleep disorder linked to swine flu vaccination.
[No authors listed]
Nurs Stand. 2014 Feb 12;28(24):16. doi: 10.7748/ns2014.02.28.24.16.s20.
PMID: 24517667
9
[PubMed - in process]
Related citations
Select item 24517198 16.
A sham case-control study of effectiveness of DTP-Hib-hepatitis B vaccine against rotavirus acute gastroenteritis in Kenya.
Khagayi S, Tate JE, Onkoba R, Parashar U, Odhiambo F, Burton D, Laserson K, Feikin DR.
BMC Infect Dis. 2014 Feb 11;14(1):77. [Epub ahead of print]
PMID: 24517198 [PubMed - as supplied by publisher]
Related citations
Select item 24517188 17.
HIV-1 Vaccine Strategies Utilizing Viral Vectors Including Antigen-Displayed Inoviral Vectors.
Hassapis KA, Kostrikis LG.
Curr HIV Res. 2014 Feb 9. [Epub ahead of print]
PMID: 24517188 [PubMed - as supplied by publisher]
Related citations
Select item 24517171 18.
Injection Route and TLR9 Agonist Addition Significantly Impact Heroin Vaccine Efficacy.
Bremer PT, Schlosburg JE, Lively JM, Janda KD.
Mol Pharm. 2014 Feb 11. [Epub ahead of print]
PMID: 24517171 [PubMed - as supplied by publisher]
Related citations
10
Select item 24516697 19.
Evaluation of antibody response to polysaccharide vaccine and switched memory B cells in pediatric patients with inflammatory bowel disease.
Fallahi G, Aghamohammadi A, Khodadad A, Hashemi M, Mohammadinejad P, Asgarian- Omran H, Najafi M, Farhmand F, Motamed F, Soleimani K, Soheili H, Parvaneh N, Darabi B, Nasiri Kalmarzi R, Pourhamdi S, Abolhassani H, Mirminachi B, Rezaei N.
Gut Liver. 2014 Jan;8(1):24-8. doi: 10.5009/gnl.2014.8.1.24. Epub 2013 Aug 14.
PMID: 24516697 [PubMed - in process] Free Article
Related citations
Select item 24516685 20.
Evaluation in Mice of a Conjugate Vaccine for Cholera Made from Vibrio cholerae O1 (Ogawa) O-Specific Polysaccharide.
Alam MM, Bufano MK, Xu P, Kalsy A, Yu Y, Freeman YW, Sultana T, Rashu MR, Desai I, Eckhoff G, Leung DT, Charles RC, Larocque RC, Harris JB, Clements JD, Calderwood SB, Qadri F, Vann WF, Kováč P, Ryan ET.
PLoS Negl Trop Dis. 2014 Feb 6;8(2):e2683. doi: 10.1371/journal.pntd.0002683. eCollection 2014 Feb.
PMID: 24516685 [PubMed - in process] Free Article
Related citations
Select item 24516675 21.
Mass vaccination with a new, less expensive oral cholera vaccine using public health infrastructure in India: the odisha model.
Kar SK, Sah B, Patnaik B, Kim YH, Kerketta AS, Shin S, Rath SB, Ali M, Mogasale V, Khuntia HK, Bhattachan A, You YA, Puri MK, Lopez AL, Maskery B, Nair GB, Clemens JD, Wierzba TF.
PLoS Negl Trop Dis. 2014 Feb 6;8(2):e2629. doi: 10.1371/journal.pntd.0002629. eCollection 2014 Feb.
PMID: 24516675 [PubMed - in process]
11
Free Article
Related citations
Select item 24516595 22.
Methods to Assess the Impact of Mass Oral Cholera Vaccination Campaigns under Real Field Conditions.
Deen J, Ali M, Sack D.
PLoS One. 2014 Feb 7;9(2):e88139. doi: 10.1371/journal.pone.0088139. eCollection 2014.
PMID: 24516595 [PubMed - in process] Free Article
Related citations
Select item 24516377 23.
Correction: Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1.
Dutta S, Dlugosz LS, Drew DR, Ge X, Ababacar D, Rovira YI, Moch JK, Shi M, Long CA, Foley M, Beeson JG, Anders RF, Miura K, Haynes JD, Batchelor AH.
PLoS Pathog. 2014 Jan 24;10(1). doi: 10.1371/annotation/be0d67d1-314f-4654-8a2f- b668d1e32bbd. eCollection 2014 Jan.
PMID: 24516377 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 24516173 24.
Epidemiological evidence for herd immunity induced by acellular pertussis vaccines.
Domenech de Cellès M, Riolo MA, Magpantay FM, Rohani P, King AA.
Proc Natl Acad Sci U S A. 2014 Feb 10. [Epub ahead of print] No abstract available.
PMID: 24516173 [PubMed - as supplied by publisher]
12
Related citations
Select item 24515514 25.
Duration of Protection After First Dose of Acellular Pertussis Vaccine in Infants.
Quinn HE, Snelling TL, Macartney KK, McIntyre PB.
Pediatrics. 2014 Feb 10. [Epub ahead of print]
PMID: 24515514 [PubMed - as supplied by publisher]
Related citations
Select item 24515506 26.
A 6-Month-Old With Vaccine-Hesitant Parents.
Opel DJ, Feemster KA, Omer SB, Orenstein WA, Richter M, Lantos JD.
Pediatrics. 2014 Feb 10. [Epub ahead of print]
PMID: 24515506 [PubMed - as supplied by publisher]
Related citations
Select item 24514956 27.
A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates.
Jochems C, Tucker JA, Tsang KY, Madan RA, Dahut WL, Liewehr DJ, Steinberg SM, Gulley JL, Schlom J.
Cancer Immunol Immunother. 2014 Feb 11. [Epub ahead of print]
PMID: 24514956 [PubMed - as supplied by publisher]
Related citations
Select item 24514081 28.
The Spectrum Of Post Vaccination Inflammatory Cns Demyelinating Syndromes.
13
Karussis D, Petrou P.
Autoimmun Rev. 2013 Oct 25. pii: S1568-9972(13)00178-X. doi: 10.1016/j.autrev.2013.10.003. [Epub ahead of print] No abstract available.
PMID: 24514081 [PubMed - as supplied by publisher]
Related citations
Select item 24513715 29.
Listeria monocytogenes: A promising vehicle for neonatal vaccination.
Liang ZZ, Sherrid AM, Wallecha A, Kollmann TR.
Hum Vaccin Immunother. 2014 Feb 10;10(4). [Epub ahead of print] Review.
PMID: 24513715 [PubMed - as supplied by publisher]
Related citations
Select item 24513675 30.
Intralymphatic immunotherapy and vaccination in mice.
Johansen P, Kündig TM.
J Vis Exp. 2014 Feb 2;(84). doi: 10.3791/51031.
PMID: 24513675 [PubMed - in process]
Related citations
Select item 24513632 31.
Reduced MyD88 dependency of ISCOMATRIX™ adjuvant in a DNA prime-protein boost HIV vaccine.
Buglione-Corbett R, Pouliot K, Marty-Roix R, Li W, West K, Wang S, Baz Morelli A, Lien E, Lu S.
Hum Vaccin Immunother. 2014 Feb 10;10(4). [Epub ahead of print]
PMID: 24513632
14
[PubMed - as supplied by publisher]
Related citations
Select item 24513504 32.
Measles epidemic from 1951 to 2012 and vaccine effectiveness in Guangzhou, southern China.
Yang Z, Xu J, Wang M, Di B, Tan H, He Q, Cai Y, Liang J, Hu W, Dong Z, Fu C.
Hum Vaccin Immunother. 2014 Feb 10;10(4). [Epub ahead of print]
PMID: 24513504 [PubMed - as supplied by publisher]
Related citations
Select item 24513277 33.
Recombinant feline coronaviruses as vaccine candidates confer protection in SPF but not in conventional cats.
Bálint A, Farsang A, Szeredi L, Zádori Z, Belák S.
Vet Microbiol. 2013 Oct 29. pii: S0378-1135(13)00488-4. doi: 10.1016/j.vetmic.2013.10.015. [Epub ahead of print]
PMID: 24513277 [PubMed - as supplied by publisher]
Related citations
Select item 24513243 34.
Vaccination models and optimal control strategies to dengue.
Rodrigues HS, Monteiro MT, Torres DF.
Math Biosci. 2013 Oct 24. pii: S0025-5564(13)00242-3. doi: 10.1016/j.mbs.2013.10.006. [Epub ahead of print]
PMID: 24513243 [PubMed - as supplied by publisher]
Related citations
15
Select item 24513012 35.
Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage.
Smits G, Mollema L, Hahné S, de Melker H, Tcherniaeva I, van der Klis F, Berbers G.
Vaccine. 2014 Feb 7. pii: S0264-410X(14)00118-2. doi: 10.1016/j.vaccine.2014.01.066. [Epub ahead of print]
PMID: 24513012 [PubMed - as supplied by publisher]
Related citations
Select item 24513011 36.
Disorganized muscle protein-1 (DIM-1) of filarial parasite Brugia malayi: cDNA cloning, expression, purification, structural modeling and its potential as vaccine candidate for human filarial infection.
Kushwaha V, Kumar V, Verma SK, Sharma R, Siddiqi MI, Murthy PK.
Vaccine. 2014 Feb 7. pii: S0264-410X(14)00116-9. doi: 10.1016/j.vaccine.2014.01.064. [Epub ahead of print]
PMID: 24513011 [PubMed - as supplied by publisher]
Related citations
Select item 24513010 37.
Vaccination with a piggyBac plasmid with transgene integration potential leads to sustained antigen expression and CD8+ T cell responses.
Bertino P, Urschitz J, Hoffmann FW, You BR, Rose AH, Park WH, Moisyadi S, Hoffmann PR.
Vaccine. 2014 Feb 7. pii: S0264-410X(14)00115-7. doi: 10.1016/j.vaccine.2014.01.063. [Epub ahead of print]
PMID: 24513010 [PubMed - as supplied by publisher]
Related citations
Select item 24513009 38. 16
The link between genetic variation and variability in vaccine responses: Systematic review and meta-analyses.
Posteraro B, Pastorino R, Di Giannantonio P, Ianuale C, Amore R, Ricciardi W, Boccia S.
Vaccine. 2014 Feb 7. pii: S0264-410X(14)00109-1. doi: 10.1016/j.vaccine.2014.01.057. [Epub ahead of print]
PMID: 24513009 [PubMed - as supplied by publisher]
Related citations
Select item 24513008 39.
Methodological quality of systematic reviews on influenza vaccination.
Remschmidt C, Wichmann O, Harder T.
Vaccine. 2014 Feb 7. pii: S0264-410X(14)00112-1. doi: 10.1016/j.vaccine.2014.01.060. [Epub ahead of print]
PMID: 24513008 [PubMed - as supplied by publisher]
Related citations
Select item 24512961 40.
Minipigs as an animal model for dermal vaccine delivery.
Ploemen IH, Hirschberg HJ, Kraan H, Zeltner A, van Kuijk S, Lankveld DP, Royals M, Kersten GF, Amorij JP.
Comp Med. 2014;64(1):50-4.
PMID: 24512961 [PubMed - in process]
Related citations
Select item 24512916 41.
A novel multi-epitope peptide vaccine against cancer: an in silico approach.
Nezafat N, Ghasemi Y, Rahbar MR, Javadi G, Khoshnoud MJ, Omidinia E.
17
J Theor Biol. 2014 Feb 7. pii: S0022-5193(14)00035-6. doi: 10.1016/j.jtbi.2014.01.018. [Epub ahead of print]
PMID: 24512916 [PubMed - as supplied by publisher]
Related citations
Select item 24512806 42.
[Catch-up vaccination of worldwide newcoming (adopted, refugee or migrant) children in France.] de Monléon JV, Regnier F, Ajana F, Baptiste C, Callamand P, Cheymol J, Gillet Y, Hau- Rainsard I, Lorrot M, Reinert P, Marchand S, Okaïs C, Picherot G; Avancées Vaccinales.
Arch Pediatr. 2014 Feb 7. pii: S0929-693X(13)00641-6. doi: 10.1016/j.arcped.2013.12.003. [Epub ahead of print] French.
PMID: 24512806 [PubMed - as supplied by publisher]
Related citations
Select item 24512430 43.
High ICU admission rate for 2013-2014 Influenza is associated with a low rate of vaccination.
Catania J, Que LG, Govert JA, Hollingsworth JW, Wolfe CR.
Am J Respir Crit Care Med. 2014 Feb 10. [Epub ahead of print] No abstract available.
PMID: 24512430 [PubMed - as supplied by publisher]
Related citations
Select item 24512188 44.
Influence of parenteral administration routes and additional factors on vaccine safety and immunogenicity: a review of recent literature.
Herzog C.
Expert Rev Vaccines. 2014 Feb 10. [Epub ahead of print]
PMID:
18
24512188 [PubMed - as supplied by publisher]
Related citations
Select item 24511823 45.
[Possibilities and limitations in veterinary vaccine development using the example of classical swine fever].
Blome S, Gabriel C, Beer M.
Berl Munch Tierarztl Wochenschr. 2013 Nov-Dec;126(11-12):481-90. German.
PMID: 24511823 [PubMed - in process]
Related citations
Select item 24511822 46.
Prospects of improved classical swine fever control in backyard pigs through oral vaccination.
Dietze K, Milicevic V, Depner K.
Berl Munch Tierarztl Wochenschr. 2013 Nov-Dec;126(11-12):476-80.
PMID: 24511822 [PubMed - in process]
Related citations
Select item 24511686 47.
Protection against Fasciola gigantica using paramyosin antigen as a candidate for vaccine production.
Abou-Elhakam H, Rabee I, El Deeb S, El Amir A.
Pak J Biol Sci. 2013 Nov 15;16(22):1449-58.
PMID: 24511686 [PubMed - in process]
Related citations
19
Select item 24510948 48.
Pathologic Characterization of Genotypes XIV and XVII Newcastle Disease Viruses and Efficacy of Classical Vaccination on Specific Pathogen-Free Birds.
Susta L, Jones ME, Cattoli G, Cardenas-Garcia S, Miller PJ, Brown CC, Afonso CL.
Vet Pathol. 2014 Feb 7. [Epub ahead of print]
PMID: 24510948 [PubMed - as supplied by publisher]
Related citations
Select item 24510837 49.
Gene-based vaccination and screening methods to develop monoclonal antibodies.
Daftarian MP, Vosoughi A, Lemmon V.
Methods Mol Biol. 2014;1121:337-46. doi: 10.1007/978-1-4614-9632-8_30.
PMID: 24510837 [PubMed - in process]
Related citations
Select item 24510836 50.
DNA Electroporation of Multi-agent Vaccines Conferring Protection Against Select Agent Challenge: TriGrid Delivery System.
Keane-Myers AM, Bell M, Hannaman D, Albrecht M.
Methods Mol Biol. 2014;1121:325-36. doi: 10.1007/978-1-4614-9632-8_29.
PMID: 24510836 [PubMed - in process]
Related citations
Select item 24510835 51.
Intramuscular DNA vaccination protocols mediated by electric fields.
Chiarella P, Signori E.
20
Methods Mol Biol. 2014;1121:315-24. doi: 10.1007/978-1-4614-9632-8_28.
PMID: 24510835 [PubMed - in process]
Related citations
Select item 24510834 52.
Electroporation-mediated intradermal delivery of DNA vaccines in nonhuman primates.
Adam L, Le Grand R, Martinon F.
Methods Mol Biol. 2014;1121:309-13. doi: 10.1007/978-1-4614-9632-8_27.
PMID: 24510834 [PubMed - in process]
Related citations
Select item 24510833 53.
Electroporation-Mediated Administration of Candidate DNA Vaccines Against HIV-1.
Vasan S.
Methods Mol Biol. 2014;1121:291-307. doi: 10.1007/978-1-4614-9632-8_26.
PMID: 24510833 [PubMed - in process]
Related citations
Select item 24510832 54.
Clinical development of intramuscular electroporation: providing a "boost" for DNA vaccines.
Khan AS, Broderick KE, Sardesai NY.
Methods Mol Biol. 2014;1121:279-89. doi: 10.1007/978-1-4614-9632-8_25.
PMID: 24510832 [PubMed - in process]
Related citations
21
Select item 24510831 55.
Evolution of electroporated DNA vaccines.
Keane-Myers AM, Bell M.
Methods Mol Biol. 2014;1121:269-78. doi: 10.1007/978-1-4614-9632-8_24.
PMID: 24510831 [PubMed - in process]
Related citations
Select item 24510515 56.
Nonhuman Primate Models for HIV/AIDS Vaccine Development.
Sui Y, Gordon S, Franchini G, Berzofsky JA.
Curr Protoc Immunol. 2013 Oct 1;102:12.14.1-12.14.30. doi: 10.1002/0471142735.im1214s102.
PMID: 24510515 [PubMed - in process]
Related citations
Select item 24510145 57.
TAPCells, the Chilean dendritic cell vaccine against melanoma and prostate cancer.
Salazar-Onfray F, Pereda C, Reyes D, López MN.
Biol Res. 2013;46(4):431-40. doi: 10.4067/S0716-97602013000400014.
PMID: 24510145 [PubMed - in process] Free Article
Related citations
Select item 24510143 58.
Nanoparticles and microparticles of polymers and polysaccharides to administer fish vaccines.
Rivas-Aravena A, Sandino AM, Spencer E.
22
Biol Res. 2013;46(4):407-19. doi: 10.4067/S0716-97602013000400012.
PMID: 24510143 [PubMed - in process] Free Article
Related citations
Select item 24509607 59.
A recombinant chimeric protein containing B chains of ricin and abrin is an effective vaccine candidate.
Wang J, Gao S, Zhang T, Kang L, Xu N, Liu W, Wang J.
Hum Vaccin Immunother. 2014 Feb 7;10(4). [Epub ahead of print]
PMID: 24509607 [PubMed - as supplied by publisher]
Related citations
Select item 24509522 60.
Safety, specificity and immunogenicity of a PrPSc-specific prion vaccine based on the YYR disease specific epitope.
Taschuk R, Marciniuk K, Määttänen P, Madampage C, Hedlin P, Potter A, Lee J, Cashman NR, Griebel P, Napper S.
Prion. 2014 Feb 7;8(1). [Epub ahead of print] Review.
PMID: 24509522 [PubMed - as supplied by publisher]
Related citations
Select item 24509239 61.
Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB/c mice.
Bian C, Liu S, Liu N, Zhang G, Xing L, Song Y, Duan Y, Gu H, Zhou Y, Zhang P, Li Z, Zhang K, Wang Z, Zhang S, Wang X, Yang P.
Antiviral Res. 2014 Feb 6. pii: S0166-3542(14)00034-5. doi: 10.1016/j.antiviral.2014.01.022. [Epub ahead of print]
23
PMID: 24509239 [PubMed - as supplied by publisher]
Related citations
Select item 24509231 62.
Is cancer vaccination feasible at older age?
Gravekamp C, Jahangir A.
Exp Gerontol. 2014 Feb 5. pii: S0531-5565(14)00037-0. doi: 10.1016/j.exger.2014.01.025. [Epub ahead of print]
PMID: 24509231 [PubMed - as supplied by publisher]
Related citations
Select item 24509173 63.
Wilms Tumor Gene (WT1) Peptide-based Cancer Vaccine Combined With Gemcitabine for Patients With Advanced Pancreatic Cancer.
Nishida S, Koido S, Takeda Y, Homma S, Komita H, Takahara A, Morita S, Ito T, Morimoto S, Hara K, Tsuboi A, Oka Y, Yanagisawa S, Toyama Y, Ikegami M, Kitagawa T, Eguchi H, Wada H, Nagano H, Nakata J, Nakae Y, Hosen N, Oji Y, Tanaka T, Kawase I, Kumanogoh A, Sakamoto J, Doki Y, Mori M, Ohkusa T, Tajiri H, Sugiyama H.
J Immunother. 2014 Feb-Mar;37(2):105-14. doi: 10.1097/CJI.0000000000000020.
PMID: 24509173 [PubMed - in process]
Related citations
Select item 24509171 64.
Vaccination With NY-ESO-1 Overlapping Peptides Mixed With Picibanil OK-432 and Montanide ISA-51 in Patients With Cancers Expressing the NY-ESO-1 Antigen.
Wada H, Isobe M, Kakimi K, Mizote Y, Eikawa S, Sato E, Takigawa N, Kiura K, Tsuji K, Iwatsuki K, Yamasaki M, Miyata H, Matsushita H, Udono H, Seto Y, Yamada K, Nishikawa H, Pan L, Venhaus R, Oka M, Doki Y, Nakayama E.
J Immunother. 2014 Feb-Mar;37(2):84-92. doi: 10.1097/CJI.0000000000000017.
PMID: 24509171 24
[PubMed - in process]
Related citations
Select item 24508336 65.
Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case- control study.
Ichihara MY, Rodrigues LC, Teles Santos CA, Teixeira MD, De Jesus SR, Alvim De Matos SM, Gagliardi Leite JP, Barreto ML.
Vaccine. 2014 Feb 4. pii: S0264-410X(14)00008-5. doi: 10.1016/j.vaccine.2014.01.007. [Epub ahead of print]
PMID: 24508336 [PubMed - as supplied by publisher]
Related citations
Select item 24508311 66.
Neutralizing antibody responses to foot-and-mouth disease quadrivalent (type O, A, C and Asia 1) vaccines in growing calves with pre-existing maternal antibodies.
Patil PK, Sajjanar CM, Natarajan C, Bayry J.
Vet Microbiol. 2014 Jan 18. pii: S0378-1135(14)00027-3. doi: 10.1016/j.vetmic.2014.01.005. [Epub ahead of print]
PMID: 24508311 [PubMed - as supplied by publisher]
Related citations
Select item 24508042 67.
Model based estimates of long-term persistence of inactivated hepatitis A vaccine- induced antibodies in adults.
Hens N, Habteab Ghebretinsae A, Hardt K, Van Damme P, Van Herck K.
Vaccine. 2014 Feb 6. pii: S0264-410X(13)01497-7. doi: 10.1016/j.vaccine.2013.10.088. [Epub ahead of print]
PMID: 24508042 [PubMed - as supplied by publisher]
25
Related citations
Select item 24508039 68.
Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumonia.
Rodrigo C, Bewick T, Sheppard C, Greenwood S, Trotter C, Slack M, George R, Lim WS.
Vaccine. 2014 Feb 6. pii: S0264-410X(14)00067-X. doi: 10.1016/j.vaccine.2014.01.035. [Epub ahead of print]
PMID: 24508039 [PubMed - as supplied by publisher]
Related citations
Select item 24508037 69.
Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs.
McGettigan JP, David F, Figueiredo MD, Minke J, Mebatsion T, Schnell MJ.
Vaccine. 2014 Feb 6. pii: S0264-410X(14)00077-2. doi: 10.1016/j.vaccine.2014.01.043. [Epub ahead of print]
PMID: 24508037 [PubMed - as supplied by publisher]
Related citations
Select item 24508036 70.
Safety and immunogenicity of three different formulations of an adjuvanted varicella- zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study.
Chlibek R, Smetana J, Pauksens K, Rombo L, Van den Hoek JA, Richardus JH, Plassmann G, Schwarz TF, Ledent E, Heineman TC.
Vaccine. 2014 Feb 6. pii: S0264-410X(14)00051-6. doi: 10.1016/j.vaccine.2014.01.019. [Epub ahead of print]
PMID: 24508036 [PubMed - as supplied by publisher]
Related citations
26
Select item 24508035 71.
Immunization with a DNA adenine methylase over-producing Yersinia pseudotuberculosis vaccine confers robust cross-protection against heterologous pathogenic serotypes.
Kubicek-Sutherland JZ, Heithoff DM, Ersoy SC, Shimp WR, Mahan MJ.
Vaccine. 2014 Feb 6. pii: S0264-410X(14)00068-1. doi: 10.1016/j.vaccine.2014.01.036. [Epub ahead of print]
PMID: 24508035 [PubMed - as supplied by publisher]
Related citations
Select item 24508034 72.
Evaluation of the immunogenicity and safety of Brucella melitensis B115 vaccination in pregnant sheep.
Pérez-Sancho M, Adone R, García-Seco T, Tarantino M, Diez-Guerrier A, Drumo R, Francia M, Domínguez L, Pasquali P, Alvarez J.
Vaccine. 2014 Feb 6. pii: S0264-410X(14)00122-4. doi: 10.1016/j.vaccine.2014.01.070. [Epub ahead of print]
PMID: 24508034 [PubMed - as supplied by publisher]
Related citations
Select item 24507702 73.
LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4+ and CD8+) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.
Aguiar-Soares RD, Roatt BM, Ker HG, Moreira ND, Mathias FA, Cardoso JM, Gontijo NF, Bruna-Romero O, Teixeira-Carvalho A, Martins-Filho OA, Corrêa-Oliveira R, Giunchetti RC, Reis AB.
Parasit Vectors. 2014 Feb 7;7(1):61. [Epub ahead of print]
PMID: 24507702 [PubMed - as supplied by publisher] Free Article
Related citations 27
Select item 24507659 74.
Anti-idiotypic antibodies reduce efficacy of the attenuated vaccine against highly pathogenic PRRSV challenge.
Yu Y, Cai X, Wang G, Kong N, Liu Y, Xiao Y, Zhang C, Mu Y, Xiao S, Zhao Q, Wang C, Zhang G, Hiscox JA, Zhou EM.
BMC Vet Res. 2014 Feb 8;10(1):39. [Epub ahead of print]
PMID: 24507659 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 24507620 75.
Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines.
Davtyan H, Ghochikyan A, Hovakimyan A, Petrushina I, Yu J, Flyer D, Madsen PJ, Pedersen LO, Cribbs DH, Agadjanyan MG.
J Neuroimmunol. 2014 Jan 15. pii: S0165-5728(14)00005-8. doi: 10.1016/j.jneuroim.2014.01.002. [Epub ahead of print]
PMID: 24507620 [PubMed - as supplied by publisher]
Related citations
Select item 24507480 76.
Modeling the impact of the 7-valent pneumococcal conjugate vaccine in Chinese infants: an economic analysis of a compulsory vaccination.
Che D, Zhou H, He J, Wu B.
BMC Health Serv Res. 2014 Feb 7;14(1):56. [Epub ahead of print]
PMID: 24507480 [PubMed - as supplied by publisher] Free PMC Article
Related citations
Select item 24507384 77. 28
Chinese immigrant parents' vaccination decision making for children: a qualitative analysis.
Wang LD, Lam WW, Wu JT, Liao Q, Fielding R.
BMC Public Health. 2014 Feb 7;14(1):133. [Epub ahead of print]
PMID: 24507384 [PubMed - as supplied by publisher] Free Article
Related citations
Select item 24506428 78.
Experimental Oral Immunization of Ferret Badgers (Melogale moschata) with a Recombinant Canine Adenovirus Vaccine CAV-2-E3Δ-RGP and an Attenuated Rabies Virus SRV9.
Zhao J, Liu Y, Zhang S, Fang L, Zhang F, Hu R.
J Wildl Dis. 2014 Feb 7. [Epub ahead of print]
PMID: 24506428 [PubMed - as supplied by publisher]
Related citations
Select item 24506127 79.
Influenza vaccine reduces risk of adverse cardiovascular events in high-risk patients.
Slawson D.
Am Fam Physician. 2014 Feb 1;89(3):224-5. No abstract available.
PMID: 24506127 [PubMed - in process]
Related citations
Select item 24506115 80.
What's New in Childhood Vaccines.
Rockwell P.
Am Fam Physician. 2014 Feb 1;89(3):153-8. No abstract available.
29
PMID: 24506115 [PubMed - in process]
Related citations
Select item 24505843 81.
Biopharming, bananas and bureaucracy: the banana vaccine as a case study for products that straddle the definitional food/drug divide.
Birdsall M.
Food Drug Law J. 2011;66(2):265-83, iii.
PMID: 24505843 [PubMed - in process]
Related citations
Select item 24505283 82.
Two Types of Antibodies Are Induced by Vaccination with A/California/2009pdm Virus: Binding near the Sialic Acid-Binding Pocket and Neutralizing Both H1N1 and H5N1 Viruses.
Ohshima N, Kubota-Koketsu R, Iba Y, Okuno Y, Kurosawa Y.
PLoS One. 2014 Feb 5;9(2):e87305. doi: 10.1371/journal.pone.0087305. eCollection 2014.
PMID: 24505283 [PubMed - in process] Free PMC Article
Related citations
Select item 24505274 83.
Positive network assortativity of influenza vaccination at a high school: implications for outbreak risk and herd immunity.
Barclay VC, Smieszek T, He J, Cao G, Rainey JJ, Gao H, Uzicanin A, Salathé M.
PLoS One. 2014 Feb 5;9(2):e87042. doi: 10.1371/journal.pone.0087042. eCollection 2014.
PMID: 24505274 [PubMed - in process] 30
Free PMC Article
Related citations
Select item 24505241 84.
Construction and Evaluation of V. cholerae O139 Mutant, VCUSM21P, as a Safe Live Attenuated Cholera Vaccine.
Murugaiah C, Nik Mohd Noor NZ, Mustafa S, Manickam R, Pattabhiraman L.
PLoS One. 2014 Feb 5;9(2):e81817. doi: 10.1371/journal.pone.0081817. eCollection 2014.
PMID: 24505241 [PubMed - in process] Free PMC Article
Related citations
Select item 24504509 85.
Vaccine-Induced IgG Antibodies to V1V2 Regions of Multiple HIV-1 Subtypes Correlate with Decreased Risk of HIV-1 Infection.
Zolla-Pazner S, Decamp A, Gilbert PB, Williams C, Yates NL, Williams WT, Howington R, Fong Y, Morris DE, Soderberg KA, Irene C, Reichman C, Pinter A, Parks R, Pitisuttithum P, Kaewkungwal J, Rerks-Ngarm S, Nitayaphan S, Andrews C, O'Connell RJ, Yang ZY, Nabel GJ, Kim JH, Michael NL, Montefiori DC, Liao HX, Haynes BF, Tomaras GD.
PLoS One. 2014 Feb 4;9(2):e87572. doi: 10.1371/journal.pone.0087572. eCollection 2014.
PMID: 24504509 [PubMed - in process] Free PMC Article
Related citations
Select item 24504133 86.
The future for vaccine development against Entamoeba histolytica.
Quach J, St-Pierre J, Chadee K.
Hum Vaccin Immunother. 2014 Feb 6;10(6). [Epub ahead of print] Review.
PMID: 24504133 [PubMed - as supplied by publisher] 31
Related citations
Select item 24503629 87.
Influenza vaccination coverage and factors affecting adherence to influenza vaccination among patients with diabetes in Taiwan.
Yu MC, Chou YL, Lee PL, Yang YC, Chen KT.
Hum Vaccin Immunother. 2014 Feb 6;10(4). [Epub ahead of print]
PMID: 24503629 [PubMed - as supplied by publisher]
Related citations
Select item 24503599 88.
Effectiveness of 10-year vaccination (2001-2010) on Hepatitis A in Tianjin, China.
Zhang ZL, Zhu XJ, Shan AL, Gao ZG, Zhang Y, Ding YX, Liu H, Wu WS, Liu Y, He HY, Xie XH, Xia WD, Li C, Xu WT, Li ZY, Lin HL, Fu WM.
Hum Vaccin Immunother. 2014 Feb 6;10(4). [Epub ahead of print]
PMID: 24503599 [PubMed - as supplied by publisher]
Related citations
Select item 24503579 89.
Vaccination of Mice Using the West Nile Virus E-Protein in a DNA Prime-Protein Boost Strategy Stimulates Cell-Mediated Immunity and Protects Mice against a Lethal Challenge.
De Filette M, Soehle S, Ulbert S, Richner J, Diamond MS, Sinigaglia A, Barzon L, Roels S, Lisziewicz J, Lorincz O, Sanders NN.
PLoS One. 2014 Feb 4;9(2):e87837. doi: 10.1371/journal.pone.0087837. eCollection 2014.
PMID: 24503579 [PubMed - in process] Free PMC Article
Related citations
32
Select item 24503273 90.
Vaccinations among medical and nursing students: Coverage and opportunities.
Loulergue P, Launay O.
Vaccine. 2014 Feb 3. pii: S0264-410X(14)00023-1. doi: 10.1016/j.vaccine.2014.01.014. [Epub ahead of print]
PMID: 24503273 [PubMed - as supplied by publisher]
Related citations
Select item 24503272 91.
Safety of Japanese encephalitis live attenuated vaccination in post-marketing surveillance in Guangdong, China, 2005-2012.
Liu Y, Lin H, Zhu Q, Wu C, Zhao Z, Zheng H.
Vaccine. 2014 Feb 3. pii: S0264-410X(14)00081-4. doi: 10.1016/j.vaccine.2013.11.107. [Epub ahead of print]
PMID: 24503272 [PubMed - as supplied by publisher]
Related citations
Select item 24503271 92.
Costs of vaccine delivery in the Gambia before and after, pentavalent and pneumococcal conjugate vaccine introductions.
Usuf E, Mackenzie G, Lowe-Jallow Y, Boye B, Atherly D, Suraratdecha C, Griffiths UK.
Vaccine. 2014 Feb 3. pii: S0264-410X(14)00082-6. doi: 10.1016/j.vaccine.2014.01.045. [Epub ahead of print]
PMID: 24503271 [PubMed - as supplied by publisher]
Related citations
Select item 24503087 93.
33
Protection of non-human primates against rabies with an adenovirus recombinant vaccine.
Xiang ZQ, Greenberg L, Ertl HC, Rupprecht CE.
Virology. 2014 Feb;450-451:243-9. doi: 10.1016/j.virol.2013.12.029. Epub 2014 Jan 9.
PMID: 24503087 [PubMed - in process]
Related citations
Select item 24503086 94.
Development of a live attenuated vaccine candidate against duck Tembusu viral disease.
Li G, Gao X, Xiao Y, Liu S, Peng S, Li X, Shi Y, Zhang Y, Yu L, Wu X, Yan P, Yan L, Teng Q, Tong G, Li Z.
Virology. 2014 Feb;450-451:233-42. doi: 10.1016/j.virol.2013.12.028. Epub 2014 Jan 9.
PMID: 24503086 [PubMed - in process]
Related citations
Select item 24502935 95.
Viral warfare! Front-line defence and arming the immune system against cancer using oncolytic vaccinia and other viruses.
Dave RV, Jebar AH, Jennings VA, Adair RA, West EJ, Errington-Mais F, Toogood GJ, Melcher AA.
Surgeon. 2014 Feb 4. pii: S1479-666X(14)00006-7. doi: 10.1016/j.surge.2014.01.001. [Epub ahead of print] Review.
PMID: 24502935 [PubMed - as supplied by publisher]
Related citations
Select item 24502736 96.
Oral Vaccination of Captive Small Indian Mongoose (Herpestes auropunctatus) against Rabies.
34
Vos A, Kretzschmar A, Ortmann S, Lojkic I, Habla C, Müller T, Kaiser C, Hundt B, Schuster P.
J Wildl Dis. 2013 Oct;49(4):1033-6. doi: 10.7589/2013-02-035.
PMID: 24502736 [PubMed - in process]
Related citations
Select item 24502730 97.
Immune response to newcastle disease virus vaccination in a wild passerine.
Broggi J, García O, Miranda F, Pagès A, Soriguer RC, Figuerola J.
J Wildl Dis. 2013 Oct;49(4):1004-8. doi: 10.7589/2012-10-266.
PMID: 24502730 [PubMed - in process]
Related citations
Select item 24502690 98.
The Yin-Yang arms of vaccines: disease-fighting power versus tissue-destructive inflammation.
Tang DC, Nguyen HH.
Expert Rev Vaccines. 2014 Feb 6. [Epub ahead of print]
PMID: 24502690 [PubMed - as supplied by publisher]
Related citations
Select item 24502635 99.
Immune response in nasopharynx, lung, and blood elicited by experimental nasal pneumococcal vaccines containing live or heat-killed lactobacilli as mucosal adjuvants.
Vintiñi EO, Medina M.
Can J Physiol Pharmacol. 2014 Feb;92(2):124-31. doi: 10.1139/cjpp-2013-0227. Epub 2014 Jan 30.
PMID:
35
24502635 [PubMed - in process]
Related citations
Select item 24501540 100.
Enhancement of immunogenicity and efficacy of a plasmid DNA rabies vaccine by nanoformulation with a fourth-generation amine-terminated poly(ether imine) dendrimer.
Ullas PT, Madhusudana SN, Desai A, Sagar BK, Jayamurugan G, Rajesh YB, Jayaraman N.
Int J Nanomedicine. 2014 Jan 28;9:627-34. doi: 10.2147/IJN.S53415. eCollection 2014.
PMID: 24501540 [PubMed - in process] Free PMC Article
Related citations
Select item 24501410 101.
Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy chain lineages.
Whittle JR, Wheatley AK, Wu L, Lingwood D, Kanekiyo M, Ma SS, Narpala SR, Yassine HM, Frank GM, Yewdell JW, Ledgerwood JE, Wei CJ, McDermott AB, Graham BS, Koup RA, Nabel GJ.
J Virol. 2014 Feb 5. [Epub ahead of print]
PMID: 24501410 [PubMed - as supplied by publisher]
Related citations
Select item 24501408 102.
Vaccinia Virus Requires Glutamine but not Glucose for Efficient Replication.
Fontaine KA, Camarda R, Lagunoff M.
J Virol. 2014 Feb 5. [Epub ahead of print]
PMID: 24501408 [PubMed - as supplied by publisher] 36
Related citations
Select item 24501402 103.
Measles Vaccination of Non-Human Primates Provides Partial Protection against Infection with Canine Distemper Virus. de Vries RD, Ludlow M, Verburgh RJ, van Amerongen G, Yüksel S, Nguyen DT, McQuaid S, Osterhaus AD, Duprex WP, de Swart RL.
J Virol. 2014 Feb 5. [Epub ahead of print]
PMID: 24501402 [PubMed - as supplied by publisher]
Related citations
Select item 24501340 104.
Pulmonary BCG vaccination confers dose-dependent superior protection than subcutaneous vaccination.
Aguilo N, Toledo AM, Lopez-Roman EM, Perez-Herran E, Gormley E, Rullas-Trincado J, Angulo-Barturen I, Martin C.
Clin Vaccine Immunol. 2014 Feb 5. [Epub ahead of print]
PMID: 24501340 [PubMed - as supplied by publisher]
Related citations
Select item 24501164 105.
EMLA(R) cream: A pain-relieving strategy for childhood vaccination.
Abuelkheir M, Alsourani D, Al-Eyadhy A, Temsah MH, Meo SA, Alzamil F.
J Int Med Res. 2014 Feb 5. [Epub ahead of print]
PMID: 24501164 [PubMed - as supplied by publisher]
Related citations
Select item 24501150 106.
37
To vaccinate or not to vaccinate.
Morad M, Tenenbaum A, Merrick J.
Int J Adolesc Med Health. 2014;26(1):1. doi: 10.1515/ijamh-2014-0002. No abstract available.
PMID: 24501150 [PubMed - in process]
Related citations
Select item 24500634 107.
Introduction: Moral and Political Issues in Vaccination.
Taylor JS.
HEC Forum. 2014 Feb 6. [Epub ahead of print] No abstract available.
PMID: 24500634 [PubMed - as supplied by publisher]
Related citations
Select item 24500529 108.
Review of meningococcal vaccines with updates on immunization in adults.
Zahlanie YC, Hammadi MM, Ghanem ST, Dbaibo GS.
Hum Vaccin Immunother. 2014 Feb 5;10(4). [Epub ahead of print] Review.
PMID: 24500529 [PubMed - as supplied by publisher]
Related citations
Select item 24500396 109.
Impact of health care providers' advice on vaccine refusal for children with an acute nervous system infection.
Bozzola E, Bozzola M, Tozzi AE, Nicolosi L, Vittucci A, Villani A.
Eur J Pediatr. 2014 Feb 6. [Epub ahead of print] No abstract available.
PMID: 38
24500396 [PubMed - as supplied by publisher]
Related citations
Select item 24500362 110.
Chile votes to ban thiomersal in vaccines despite opposition from doctors and scientists.
Arie S.
BMJ. 2014 Feb 5;348:g1355. doi: 10.1136/bmj.g1355. No abstract available.
PMID: 24500362 [PubMed - in process]
Related citations
Select item 24500288 111.
Noninfluenza vaccination coverage among adults - United States, 2012.
Williams WW, Lu PJ, O'Halloran A, Bridges CB, Pilishvili T, Hales CM, Markowitz LE; Immunization Services Division.
MMWR Morb Mortal Wkly Rep. 2014 Feb 7;63(5):95-102.
PMID: 24500288 [PubMed - in process] Free Article
Related citations
Select item 24500059 112.
Pentavalent Vaccine and Adverse Events Following Immunization-Untangling the Misinterpretations.
Malik A.
Indian J Pediatr. 2014 Feb 7. [Epub ahead of print]
PMID: 24500059 [PubMed - as supplied by publisher]
Related citations
39
Select item 24499824 113.
Asymptomatic memory CD8+ T cells: From development and regulation to consideration for human vaccines and immunotherapeutics.
Khan AA, Srivastava R, Lopes PP, Wang C, Pham TT, Cochrane J, Thai NT, Gutierrez L, Benmohamed L.
Hum Vaccin Immunother. 2014 Feb 5;10(4). [Epub ahead of print] Review.
PMID: 24499824 [PubMed - as supplied by publisher]
Related citations
Select item 24499818 114.
Proof of principle for epitope-focused vaccine design.
Correia BE, Bates JT, Loomis RJ, Baneyx G, Carrico C, Jardine JG, Rupert P, Correnti C, Kalyuzhniy O, Vittal V, Connell MJ, Stevens E, Schroeter A, Chen M, Macpherson S, Serra AM, Adachi Y, Holmes MA, Li Y, Klevit RE, Graham BS, Wyatt RT, Baker D, Strong RK, Crowe JE, Johnson PR, Schief WR.
Nature. 2014 Feb 5. doi: 10.1038/nature12966. [Epub ahead of print]
PMID: 24499818 [PubMed - as supplied by publisher]
Related citations
Select item 24499806 115.
Toward the development of monoclonal antibody-based assays to probe virion-like epitopes in hepatitis B vaccine antigen.
Zhu Y, Zhang T, Zhao J, Weng Z, Yuan Q, Li S, Zhang J, Xia N, Zhao Q.
Hum Vaccin Immunother. 2014 Feb 5;10(4). [Epub ahead of print]
PMID: 24499806 [PubMed - as supplied by publisher]
Related citations
Select item 24499453 116.
40
Correction: "Communicate to vaccinate": the development of a taxonomy of communication interventions to improve routine childhood vaccination.
Willis N, Hill S, Kaufman J, Lewin S, Kis-Rigo J, De Castro Freire SB, Bosch-Capblanch X, Glenton C, Lin V, Robinson P, Wiysonge CS.
BMC Int Health Hum Rights. 2013 Sep 18;13(1):37. doi: 10.1186/1472-698X-13-37. No abstract available.
PMID: 24499453 [PubMed - in process] Free PMC Article
Related citations
Select item 24499210 117.
Ending AIDS--is an HIV vaccine necessary?
Fauci AS, Marston HD.
N Engl J Med. 2014 Feb 6;370(6):495-8. doi: 10.1056/NEJMp1313771. No abstract available.
PMID: 24499210 [PubMed - indexed for MEDLINE]
Related citations
Select item 24498941 118.
Construction and Immunogenicity of the DNA Vaccine of Mycobacterium Tuberculosis dormancy antigen Rv1733c.
Zhang W, Jiang H, Bai YL, Kang J, Xu ZK, Wang LM.
Scand J Immunol. 2014 Feb 5. doi: 10.1111/sji.12160. [Epub ahead of print]
PMID: 24498941 [PubMed - as supplied by publisher]
Related citations
Select item 24498901 119.
Incidence of pediatric invasive pneumococcal disease in the Island of Majorca (2008- 2010), an area with non-universal vaccination, and estimations of serotype & children population coverage by available conjugate vaccines.
41
Picazo J, Dueñas J, Ramirez A, Perez AR, Padilla E, Herrero S, Gallegos C, Culebras E, Balseiro C, Mendez C.
BMC Infect Dis. 2013 Oct 29;13:503. doi: 10.1186/1471-2334-13-503.
PMID: 24498901 [PubMed - in process] Free PMC Article
Related citations
AMEDEO - Vaccines Publicaciones (10 - 02 - 2014): 52 artículos nuevos.
Vacunas Meningococo (Neisseria meningitidis)
31. WILLIAMS JN, Weynants V, Poolman JT, Heckels JE, et al. Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens. Vaccine. 2014 Jan 30. pii: S0264-410X(14)00085. PubMed: www.amedeo.com/p2.php?id=24486354&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486354
Vacunas BCG – ONCO BCG (Mycobacterium bovis)
28. STURGILL TL, Giguere S, Berghaus LJ, Hurley DJ, et al. Comparison of antibody and cell-mediated immune responses of foals and adult horses after vaccination with live Mycobacterium bovis BCG. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00064. PubMed: www.amedeo.com/p2.php?id=24486362&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486362
Vacunas Neumococo (Streptococcus pneumoniae)
13. PIREZ MC, Algorta G, Chamorro F, Romero C, et al. Changes in Hospitalizations for Pneumonia after Universal Vaccination with Pneumococcal Conjugate Vaccines 7/13 Valent and Haemophilus influenzae Type b Conjugate Vaccine in a Pediatric Referral Hospital in Uruguay. Pediatr Infect Dis J. 2014. PubMed: www.amedeo.com/p2.php?id=24492286&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24492286
22. SIRIWARDENA AN, Asghar Z, Coupland CA. Influenza and pneumococcal vaccination and risk of stroke or transient ischaemic attack-Matched case control study. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00061. PubMed: www.amedeo.com/p2.php?id=24486370&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486370
24. TAMURA K, Matsubara K, Ishiwada N, Nishi J, et al. Hyporesponsiveness to the infecting serotype after vaccination of children with seven-valent pneumococcal conjugate vaccine following invasive pneumococcal disease.
42
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00063. PubMed: www.amedeo.com/p2.php?id=24486367&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486367
26. PASINATO A, Indolfi G, Marchisio P, Valleriani C, et al. Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00055. PubMed: www.amedeo.com/p2.php?id=24486364&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486364
35. LIAKOU CD, Askiti V, Mitsioni A, Stefanidis CJ, et al. Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine. 2014 Jan 30. pii: S0264-410X(14)00080. PubMed: www.amedeo.com/p2.php?id=24486348&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486348
37. DE WALS P, Lefebvre B, Markowski F, Deceuninck G, et al. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada. Vaccine. 2014 Jan 30. pii: S0264-410X(13)01545. PubMed: www.amedeo.com/p2.php?id=24486346&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486346
Vacuna Tuberculosis (Mycobacterium tuberculosis)
39. WATANABE K, Matsubara A, Kawano M, Mizuno S, et al. Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization. Vaccine. 2014 Jan 29. pii: S0264-410X(14)00087. PubMed: www.amedeo.com/p2.php?id=24486310&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486310
Adyuvantes
50. CALABRO S, Tritto E, Pezzotti A, Taccone M, et al. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect. Vaccine. 2013;31:3363-9. PubMed: www.amedeo.com/p2.php?id=23684834&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23684834
Vacunas, otras
1. ARIE S. Chile votes to ban thiomersal in vaccines despite opposition from doctors and scientists. BMJ. 2014;348:g1355. PubMed: www.amedeo.com/p2.php?id=24500362&s=vac&pm=badc2a9eebb0fad
Share: http://m.amedeo.com/24500362
2. JACOB JA. "Vaccine hesitant" parents affect vaccination rates in some communities. BMJ. 2014;348:g1211. 43
PubMed: www.amedeo.com/p2.php?id=24496468&s=vac&pm=badc2a9eebb0fad
Share: http://m.amedeo.com/24496468
3. WALL EC, Everett DB, Mukaka M, Bar-Zeev N, et al. Bacterial meningitis in Malawian adults, adolescents and children during the era of antiretroviral scale-up and Hib vaccination (2000-2012). Clin Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=24496208&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24496208
4. LI J, Chang J, Liu X, Yang J, et al. Protection from Lethal Challenge in a Neonatal Mouse Model by Circulating Recombinant Form Coxsackievirus A16 Vaccine Candidates. J Gen Virol. 2014 Feb 4. doi: 10.1099/vir.0.063560. PubMed: www.amedeo.com/p2.php?id=24496826&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24496826
5. CAO RG, Suarez NM, Obermoser G, Lopez SM, et al. Differences in Antibody Responses between TIV and LAIV Influenza Vaccines Correlate with the Kinetics and Magnitude of Interferon Signaling in Children. J Infect Dis. 2014. PubMed: www.amedeo.com/p2.php?id=24495909&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24495909
6. WHITTLE JR, Wheatley AK, Wu L, Lingwood D, et al. Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy chain lineages. J Virol. 2014. PubMed: www.amedeo.com/p2.php?id=24501410&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24501410
7. FONTAINE KA, Camarda R, Lagunoff M. Vaccinia Virus Requires Glutamine but not Glucose for Efficient Replication. J Virol. 2014. PubMed: www.amedeo.com/p2.php?id=24501408&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24501408
8. DE VRIES RD, Ludlow M, Verburgh RJ, van Amerongen G, et al. Measles Vaccination of Non-Human Primates Provides Partial Protection against Infection with Canine Distemper Virus. J Virol. 2014. PubMed: www.amedeo.com/p2.php?id=24501402&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24501402
9. PRYMULA R, Bergsaker MR, Esposito S, Gothefors L, et al.
44
Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial. Lancet. 2014 Jan 28. pii: S0140-6736(12)61461. PubMed: www.amedeo.com/p2.php?id=24485548&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24485548
10. MACARTNEY K. Prevention of varicella: time for two-dose vaccination. Lancet. 2014 Jan 28. pii: S0140-6736(14)60078. PubMed: www.amedeo.com/p2.php?id=24485547&s=vac&pm=badc2a9eebb0fad
Share: http://m.amedeo.com/24485547
11. WILLIAMS WW, Lu PJ, O'Halloran A, Bridges CB, et al. Noninfluenza vaccination coverage among adults - United States, 2012. MMWR Morb Mortal Wkly Rep. 2014;63:95-102. PubMed: www.amedeo.com/p2.php?id=24500288&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24500288
12. FAUCI AS, Marston HD. Ending AIDS--is an HIV vaccine necessary? N Engl J Med. 2014;370:495-8. PubMed: www.amedeo.com/p2.php?id=24499210&s=vac&pm=badc2a9eebb0fad
Share: http://m.amedeo.com/24499210
13. PIREZ MC, Algorta G, Chamorro F, Romero C, et al. Changes in Hospitalizations for Pneumonia after Universal Vaccination with Pneumococcal Conjugate Vaccines 7/13 Valent and Haemophilus influenzae Type b Conjugate Vaccine in a Pediatric Referral Hospital in Uruguay. Pediatr Infect Dis J. 2014. PubMed: www.amedeo.com/p2.php?id=24492286&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24492286
14. MAYHEW A, Mullins TL, Ding L, Rosenthal SL, et al. Risk Perceptions and Subsequent Sexual Behaviors After HPV Vaccination in Adolescents. Pediatrics. 2014. PubMed: www.amedeo.com/p2.php?id=24488747&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24488747
15. Chen et al. Cost-effectiveness of Augmenting Universal Hepatitis B Vaccination with Immunoglobin Treatment. Pediatrics. 2013;131(4):e1135-e1143. Pediatrics. 2014;133:346. PubMed: www.amedeo.com/p2.php?id=24488301&s=vac&pm=badc2a9eebb0fad
Share: http://m.amedeo.com/24488301
45
16. MURAKAMI H, Kobayashi M, Hachiya M, Khan ZS, et al. Refusal of oral polio vaccine in northwestern Pakistan: A qualitative and quantitative study. Vaccine. 2014 Jan 31. pii: S0264-410X(14)00050. PubMed: www.amedeo.com/p2.php?id=24492016&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24492016
17. RICKERT VI, Auslander BA, Cox DS, Rosenthal SL, et al. School-based vaccination of young US males: Impact of health beliefs on intent and first dose acceptance. Vaccine. 2014 Jan 31. pii: S0264-410X(14)00088. PubMed: www.amedeo.com/p2.php?id=24492015&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24492015
18. POBRE K, Tashani M, Ridda I, Rashid H, et al. Carrier priming or suppression: Understanding carrier priming enhancement of anti-polysaccharide antibody response to conjugate vaccines. Vaccine. 2014 Jan 31. pii: S0264-410X(14)00084. PubMed: www.amedeo.com/p2.php?id=24492014&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24492014
19. SMITH HA, Rekoske BT, McNeel DG. DNA vaccines encoding altered peptide ligands for SSX2 enhance epitope-specific CD8+ T-cell immune responses. Vaccine. 2014 Jan 31. pii: S0264-410X(14)00086. PubMed: www.amedeo.com/p2.php?id=24492013&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24492013
20. ISHIKAWA T, Yamanaka A, Konishi E. A review of successful flavivirus vaccines and the problems with those flaviviruses for which vaccines are not yet available. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00074. PubMed: www.amedeo.com/p2.php?id=24486372&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486372
21. MATYAS GR, Rice KC, Cheng K, Li F, et al. Facial recognition of heroin vaccine opiates: Type 1 cross-reactivities of antibodies induced by hydrolytically stable haptenic surrogates of heroin, 6-acetylmorphine, and morphine. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00060. PubMed: www.amedeo.com/p2.php?id=24486371&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486371
22. SIRIWARDENA AN, Asghar Z, Coupland CA. Influenza and pneumococcal vaccination and risk of stroke or transient ischaemic attack-Matched case control study.
46
Vaccine. 2014 Jan 28. pii: S0264-410X(14)00061. PubMed: www.amedeo.com/p2.php?id=24486370&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486370
23. BEAU AB, Hurault-Delarue C, Vidal S, Guitard C, et al. Pandemic A/H1N1 influenza vaccination during pregnancy: A comparative study using the EFEMERIS database. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00053. PubMed: www.amedeo.com/p2.php?id=24486369&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486369
24. TAMURA K, Matsubara K, Ishiwada N, Nishi J, et al. Hyporesponsiveness to the infecting serotype after vaccination of children with seven-valent pneumococcal conjugate vaccine following invasive pneumococcal disease. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00063. PubMed: www.amedeo.com/p2.php?id=24486367&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486367
25. SOL RM, Keon M, Sabrina SC, Ines BA, et al. CD207 cells recruitment to the vaccination site and draining lymph nodes after the administration of DC-Apo/Nec vaccine in mice. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00057. PubMed: www.amedeo.com/p2.php?id=24486365&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486365
26. PASINATO A, Indolfi G, Marchisio P, Valleriani C, et al. Pneumococcal serotype distribution in 1315 nasopharyngeal swabs from a highly vaccinated cohort of Italian children as detected by RT-PCR. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00055. PubMed: www.amedeo.com/p2.php?id=24486364&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486364
27. MARCINIUK K, Maattanen P, Taschuk R, Airey TD, et al. Development of a Multivalent, PrP-Specific Prion Vaccine through Rational Optimization of Three Disease-Specific Epitopes. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00059. PubMed: www.amedeo.com/p2.php?id=24486363&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486363
28. STURGILL TL, Giguere S, Berghaus LJ, Hurley DJ, et al. Comparison of antibody and cell-mediated immune responses of foals and adult horses after vaccination with live Mycobacterium bovis BCG. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00064. PubMed: www.amedeo.com/p2.php?id=24486362&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486362
47
29. WEGWARTH O, Kurzenhauser-Carstens S, Gigerenzer G. Overcoming the knowledge-behavior gap: The effect of evidence-based HPV caccination leaflets on understanding, intention, and actual vaccination decision. Vaccine. 2014 Jan 28. pii: S0264-410X(13)01769. PubMed: www.amedeo.com/p2.php?id=24486360&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486360
30. NEWALL AT, Dehollain JP. The cost-effectiveness of influenza vaccination in elderly Australians: An exploratory analysis of the vaccine efficacy required. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00049. PubMed: www.amedeo.com/p2.php?id=24486359&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486359
31. WILLIAMS JN, Weynants V, Poolman JT, Heckels JE, et al. Immuno-proteomic analysis of human immune responses to experimental Neisseria meningitidis outer membrane vesicle vaccines identifies potential cross-reactive antigens. Vaccine. 2014 Jan 30. pii: S0264-410X(14)00085. PubMed: www.amedeo.com/p2.php?id=24486354&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486354
32. TINOCO JC, Pavia-Ruz N, Cruz-Valdez A, Doniz CA, et al. Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged >/=18 years: A phase III, randomized trial. Vaccine. 2014 Jan 28. pii: S0264-410X(14)00054. PubMed: www.amedeo.com/p2.php?id=24486352&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486352
33. FISCHER II WA, Brighton M, Jaspers I. Live attenuated influenza vaccine strains elicit a greater innate immune response than antigenically-matched seasonal influenza viruses during infection of human nasal epithelial cell cultures. Vaccine. 2014 Jan 30. pii: S0264-410X(14)00078. PubMed: www.amedeo.com/p2.php?id=24486351&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486351
34. GE J, Wang X, Tian M, Wen Z, et al. Novel in-ovo chimeric recombinant Newcastle disease vaccine protects against both Newcastle disease and infectious bursal disease. Vaccine. 2014 Jan 30. pii: S0264-410X(14)00052. PubMed: www.amedeo.com/p2.php?id=24486349&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486349
48
35. LIAKOU CD, Askiti V, Mitsioni A, Stefanidis CJ, et al. Safety and immunogenicity of booster immunization with 7-valent pneumococcal conjugate vaccine in children with idiopathic nephrotic syndrome. Vaccine. 2014 Jan 30. pii: S0264-410X(14)00080. PubMed: www.amedeo.com/p2.php?id=24486348&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486348
36. WANG X, Chen W, Tian Y, Mao Q, et al. Surface display of Clonorchis sinensis enolase on Bacillus subtilis spores potentializes an oral vaccine candidate. Vaccine. 2014 Jan 30. pii: S0264-410X(14)00073. PubMed: www.amedeo.com/p2.php?id=24486347&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486347
37. DE WALS P, Lefebvre B, Markowski F, Deceuninck G, et al. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada. Vaccine. 2014 Jan 30. pii: S0264-410X(13)01545. PubMed: www.amedeo.com/p2.php?id=24486346&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486346
38. MARTINEZ-DONATO G, Amador-Canizares Y, Alvarez-Lajonchere L, Guerra I, et al. Neutralizing antibodies and broad, functional T cell immune response following immunization with hepatitis C virus proteins-based vaccine formulation. Vaccine. 2014 Jan 30. pii: S0264-410X(14)00083. PubMed: www.amedeo.com/p2.php?id=24486345&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486345
39. WATANABE K, Matsubara A, Kawano M, Mizuno S, et al. Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization. Vaccine. 2014 Jan 29. pii: S0264-410X(14)00087. PubMed: www.amedeo.com/p2.php?id=24486310&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486310
40. QI X, Chen Y, Ren X, Zhang L, et al. A reassortment vaccine candidate as the improved formulation to induce protection against very virulent infectious bursal disease virus. Vaccine. 2014 Jan 29. pii: S0264-410X(14)00076. PubMed: www.amedeo.com/p2.php?id=24486309&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/24486309
41. FRUTH U, Broutet N, Deal C, Dodet B, et al. Vaccines for sexually transmitted infections: Past, present and future. Vaccine. 2014 Jan 27. pii: S0264-410X(14)00090.
49
PubMed: www.amedeo.com/p2.php?id=24480028&s=vac&pm=badc2a9eebb0fad
Share: http://m.amedeo.com/24480028
42. REES H, Holmes K. The STI vaccine roadmap-A long overdue intervention. Vaccine. 2014 Jan 27. pii: S0264-410X(14)00094. PubMed: www.amedeo.com/p2.php?id=24480027&s=vac&pm=badc2a9eebb0fad
Share: http://m.amedeo.com/24480027
43. KNIPE DM, Corey L, Cohen JI, Deal CD, et al. Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on "Next Generation Herpes Simplex Virus Vaccines" Vaccine. 2014 Jan 27. pii: S0264-410X(14)00091. PubMed: www.amedeo.com/p2.php?id=24480025&s=vac&pm=badc2a9eebb0fad
Share: http://m.amedeo.com/24480025
44. BROUTET N, Fruth U, Deal C, Gottlieb SL, et al. Vaccines against sexually transmitted infections: The way forward. Vaccine. 2014 Jan 27. pii: S0264-410X(14)00092. PubMed: www.amedeo.com/p2.php?id=24480024&s=vac&pm=badc2a9eebb0fad
Share: http://m.amedeo.com/24480024
45. LI HY, Han JF, Qin CF, Chen R, et al. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. Vaccine. 2013;31:3281-7. PubMed: www.amedeo.com/p2.php?id=23726823&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23726823
46. OWAIS A, Khowaja AR, Ali SA, Zaidi AK, et al. Pakistan's expanded programme on immunization: an overview in the context of polio eradication and strategies for improving coverage. Vaccine. 2013;31:3313-9. PubMed: www.amedeo.com/p2.php?id=23707167&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23707167
47. SCOTT CJ, Austin B, Austin DA, Morris PC, et al. Non-adjuvanted flagellin elicits a non-specific protective immune response in rainbow trout (Oncorhynchus mykiss, Walbaum) towards bacterial infections. Vaccine. 2013;31:3262-7. PubMed: www.amedeo.com/p2.php?id=23707165&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23707165
48. SUWANTIKA AA, Tu HA, Postma MJ. Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding
50 patterns into account. Vaccine. 2013;31:3300-7. PubMed: www.amedeo.com/p2.php?id=23707163&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23707163
49. HASHIMOTO K, Yamada S, Katano H, Fukuchi S, et al. Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta. Vaccine. 2013;31:3199-205. PubMed: www.amedeo.com/p2.php?id=23684839&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23684839
50. CALABRO S, Tritto E, Pezzotti A, Taccone M, et al. The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect. Vaccine. 2013;31:3363-9. PubMed: www.amedeo.com/p2.php?id=23684834&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23684834
51. MATULOVA M, Havlickova H, Sisak F, Babak V, et al. SPI1 defective mutants of Salmonella enterica induce cross-protective immunity in chickens against challenge with serovars Typhimurium and Enteritidis. Vaccine. 2013;31:3156-62. PubMed: www.amedeo.com/p2.php?id=23684831&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23684831
52. MITRA S, Chakrabarti MK, Koley H. Multi-serotype outer membrane vesicles of Shigellae confer passive protection to the neonatal mice against shigellosis. Vaccine. 2013;31:3163-73. PubMed: www.amedeo.com/p2.php?id=23684822&s=vac&pm=badc2a9eebb0fad ABSTRACT available Share: http://m.amedeo.com/23684822
51
PATENTES
United States Patent and Trademark Office (USPTO)
Estrategia de búsqueda “vaccine” en título y abstract
(ABST/vaccine AND ISD/20140203->20140214): 7 patentes recuperadas.
Vacuna Tuberculosis (Mycobacterium tuberculosis)
7 8,642,011 Tuberculosis vaccine
Vacunas Cólera (Vibrio cholerae)
5 8,642,046 Cholera vaccines
Vacunas, otras
PAT. Title NO.
1 8,647,643 Farnesoid-X-receptor antagonist as a vaccine adjuvant
2 8,647,640 Vaccine compositions and methods of use to protect against
infectious disease
3 8,647,634 Recombinant avian infectious coryza vaccine and process for
preparing same
4 8,647,629 Powerful MHC-class II peptides derived from survivin
5 8,642,046 Cholera vaccines
6 8,642,042 Protein matrix vaccines and methods of making and
administering such vaccines
7 8,642,011 Tuberculosis vaccine
52
European Patent Office (EPO)
Acumulado entre el 3 y el 14 de febrero de 2014: 22 patentes recuperadas.
Adyuvantes
12. VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT
Inventor: Applicant: CPC: Priority IPC: Publication info: REED STEVEN G REED STEVEN G A61K2039/55511 date:
[US] [US] A61K2039/55572 A61K39/00 US2014037691 (A1) 2006- CARTER CARTER DARRICK A61K39/0011 A61K39/39 2014-02-06 09-26 DARRICK [US] [US] (+1) (+3)
Vacunas, otras
1. METHOD FOR SPECIFIC PREVENTION OF HERD EQUINE RHINOPNEUMONIA, SALMONELLA ABORTION AND STRANGLES WITH USING ASSOCIATED VACCINE
Applicant: Inventor: G NAUCHNOE NEUSTROEV UCHREZHDENIE IPC: MIKHAIL Priority JAKUTSKIJ NII SEL Publication info: PETROVICH A61K39/09 date: SKOGO CPC: [RU] A61K39/112 RU2506093 (C1) KHOZJAJSTVA 2012- JUROV A61K39/27 2014-02-10 ROSSIJSKOJ 12-06 KONSTANTIN (+2) AKADEMII SEL PETROVICH SKOKHOZJAJSTVENN [RU] (+5) [RU]
2. Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides
Inventor: CPC: IPC: Priority FUJIOKA Applicant: Publication info: A61K2039/57 A61K38/00 date: TOMOAKI [JP] ONCOTHERAPY A61K38/00 A61K39/00 EP2695895 (A1) NAKAMURA 2006- SCIENCE INC [JP] A61K39/00 A61P35/00 2014-02-12 YUSUKE [JP] 10-17 (+3) (+3) (+3)
3. METHODS OF IMPROVING VACCINE IMMUNOGENICITY
Inventor: CPC: Priority Applicant: Publication info: BISHOP GAIL A61K2039/55505 IPC: date:
[US] UNIV IOWA RES A61K39/13 EP2694102 (A2) A61K39/13 2011- VANDEN BUSH FOUND [US] A61K39/145 2014-02-12 04-04 TONY [US] (+3)
4. PROTEASE CLEAVAGE SITE PEPTIDES AS AN HIV VACCINE
CPC: IPC: Priority Applicant: Publication info: Inventor: date: A61K2039/53 A61K39/21 CANADA NATURAL EP2694654 (A1) LUO MA [CA] A61K2039/57 A61K9/14 2011- RESOURCES [CA] 2014-02-12 A61K39/00 A61P31/18 04-07
53
(+5) (+6)
5. PROTEINS AND NUCLEIC ACIDS USEFUL IN VACCINES TARGETING STAPHYLOCOCCUS AUREUS
Inventor: CPC: IPC: Priority Publication info: MOELLER NIELS Applicant: A61K2039/505 date: A61K39/085 IVERSEN [DK] A61K2039/6081 EP2694534 (A1) NOVVAC APS [DK] C07K14/31 2011- MATTSSON A61K39/085 2014-02-12 C12Q1/68 04-08 ANDREAS [DK] (+2)
6. HIV/SIV VACCINES FOR THE GENERATION OF MUCOSAL AND SYSTEMIC IMMUNITY
Inventor: CPC: Priority Publication info: PODACK Applicant: A61K2039/6043 IPC: date:
ECKHARD R [US] A61K39/00 US2014037682 (A1) UNIV MIAMI [US] A61K39/21 2008- STRBO NATASA A61K39/21 2014-02-06 11-21 [US] (+5)
7. STABILIZING EXCIPIENT FOR INACTIVATED WHOLE VIRUS VACCINE
Inventor: CPC: IPC: Priority FRANCON ALAIN Applicant: Publication info: A61K2039/5252 A61K39/12 date: [FR] SANOFI PASTEUR A61K39/12 A61K47/02 US2014037684 (A1) CHEVALIER 2009- [FR] A61K39/205 A61K47/10 2014-02-06 MICHEL [FR] 10-07 (+6) (+2) (+4)
8. Immunization of avians by administration of non-replicating vectored vaccines
Inventor: CPC: Applicant: Priority TANG DE-CHU C Publication info: A61K2039/5256 IPC: date: [US] TANG DE-CHU C [US] A61K2039/54 US2014037679 (A1) VAN KAMPEN VAN KAMPEN KENT A61K39/145 2005- A61K2039/55 2014-02-06 KENT R [US] R [US] (+1) 08-15 (+10) (+1)
9. ANTITUMOR VACCINATION USING ALLOGENEIC TUMOR CELLS EXPRESSING ALPHA (1,3)- GALACTOSYLTRANSFERASE
Inventor: CPC: Applicant: Priority LINK JR IPC: Publication info: A01K2217/05 date: CHARLES J [US] CENTRAL IOWA A01K2267/0331 A01K67/027 US2014037692 (A1) SEREGINA HEALTH SYSTEM 2002- A01K67/0271 A61K39/00 2014-02-06 TATIANA [US] [US] 10-09 (+5) (+1)
10. CELL-BASED, ANTI-CANCER VACCINES
Priority Inventor: Publication info: Applicant: CPC: IPC: date:
AMIEL EYAL US2014037606 (A1) AMIEL EYAL [US] C12N5/0634 C12N5/078 2012- [US] 2014-02-06 08-06
11. POLYVALENT CONJUGATE VACCINE FOR CANCER
54
Inventor: CPC: IPC: Priority LIVINGSTON Applicant: Publication info: A61K2039/55577 date: PHILIP O [US] A61K39/00 SLOAN KETTERING A61K2039/6081 US2014037673 (A1) RAGUPATHI A61P35/00 2001- INST CANCER [US] A61K2039/627 2014-02-06 GOVINDASWAMI A61P37/02 07-06 (+1) [US] (+1)
12. VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT
Inventor: CPC: Applicant: Priority IPC: Publication info: REED STEVEN G A61K2039/55511 date: REED STEVEN G [US] [US] A61K2039/55572 A61K39/00 US2014037691 (A1) CARTER DARRICK 2006- CARTER A61K39/0011 A61K39/39 2014-02-06 [US] (+1) 09-26 DARRICK [US] (+3)
13. EXOPOLYSACCHARIDE OF SHIGELLA SONNEI BACTERIA, METHOD FOR PRODUCING SAME, VACCINE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME
Inventor: Applicant: APARIN PETR APARIN PETR Priority GENNADIEVICH Publication info: GENNADIEVICH CPC: IPC: date: [RU] [RU] US2014037687 (A1) LVOV A61K39/0283 A61K39/112 2011- LVOV VYACHESLAV 2014-02-06 VYACHESLAV 05-06 LEONIDOVICH [RU] LEONIDOVICH (+3) [RU] (+3)
14. PHARMACEUTICAL COMPOSITIONS AND METHODS TO VACCINATE AGAINST DISSEMINATED CANDIDIASIS AND OTHER INFECTIOUS AGENTS
Inventor: Applicant: CPC: Priority EDWARDS JR Publication info: EDWARDS JR JOHN E IPC: date: JOHN E [US] A61K39/0002 [US] US2014037689 (A1) IBRAHIM C07K16/14 A61K39/00 1999- IBRAHIM ASHRAF S 2014-02-06 ASHRAF S [US] C07K2316/96 11-19 [US] (+4) (+4)
15. Peptide and Conjugate Vaccines for Fungal Infections
Inventor: CPC: Priority Applicant: Publication info: CUTLER JIM E A61K2039/505 IPC: date:
[US] CUTLER JIM E [US] A61K2039/5158 US2014037641 (A1) C07K16/14 2011- XIN HONG [US] XIN HONG [US] (+3) A61K2039/55505 2014-02-06 04-21 (+2) (+9)
16. MATERIALS AND METHODS FOR DESIGNING AUTOLOGOUS IDIOTYPE VACCINES AND TREATMENT OF B-CELL MALIGNANCIES
Inventor: Applicant: CPC: Priority SANTOS CARLOS Publication info: SANTOS CARLOS F A61K2039/505 IPC: date: F [US] [US] A61K39/39566 US2014037615 (A1) POPA-MCKIVER A61K39/395 2010- POPA-MCKIVER C07K16/4283 2014-02-06 MIHAELA [US] 08-13 MIHAELA [US] (+3) (+1) (+2)
17. PEPTIDE VACCINES BASED ON THE EGFRvIII SEQUENCE FOR THE TREATMENT OF TUMORS
55
Applicant: Priority Inventor: Publication info: WONG ALBERT J IPC: date: [US] CPC: WONG ALBERT J WO2014022835 (A2) UNIV LELAND A61K39/00 2012- [US] 2014-02-06 STANFORD JUNIOR 08-02 [US]
18. PROBIOTIC FOR AMELIORATION OF COCCIDIOSIS VACCINE REACTION
Priority Inventor: Applicant: Publication info: IPC: date: CPC: WOLFENDEN PACIFIC VET GROUP WO2014022572 (A1) A61K39/015 2012- ROSS [US] USA INC [US] 2014-02-06 08-01
19. LIVE AND IN-VIVO TUMOR SPECIFIC CANCER VACCINE SYSTEM DEVELOPED BY CO- ADMINISTRATION OF EITHER AT LEAST TWO OR ALL THREE OF THE FOLLOWING COMPONENTS SUCH AS TUMOR CELLS, AN ONCOLYTIC VIRUS VECTOR WITH TRANSGENIC EXPRESSION OF GM-CSF AND AN IMMUNE CHECKPOINT MODULATOR
Priority Inventor: Applicant: IPC: Publication info: date: CPC: YEUNG ALEX YEUNG ALEX WAH A61K39/395 WO2014022138 (A2) 2012- WAH HIN [US] HIN [US] A61K48/00 2014-02-06 07-30
20. METHOD FOR QUALITY CONTROLLING VACCINE
Inventor: CPC: Priority Applicant: Publication info: BREUER JUDITH IPC: date: [GB] C12Q1/6834 UCL BUSINESS PLC WO2014020356 (A1) DEPLEDGE C12Q2565/518 C12Q1/68 2012- [GB] 2014-02-06 DANIEL [GB] C12Q2565/519 08-02 (+1)
21. VACCINE AGAINST INFESTATIONS CAUSED BY BLOOD-SUCKING ARTHROPODS
Inventor: Applicant: IPC: DE LA FUENTE Priority CONSEJO SUPERIOR Publication info: GARCIA JOSE DE A61K38/17 date: INVESTIGACION CPC: JESUS [ES] A61K39/00 WO2014020218 (A1) [ES] 2012- VILLAR RAYO A61P33/00 2014-02-06 UNIV CASTILLA LA 08-01 MARGARITA (+2) MANCHA [ES] [ES] (+2)
22. RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA) RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE
Inventor: CPC: Priority Applicant: IPC: Publication info: CHEMINAY date: CEDRIC [DE] A61K2039/543 BAVARIAN NORDIC A61K39/155 WO2014019718 (A1) STEIGERWALD A61K39/155 2012- AS [DK] C12Q1/68 2014-02-06 ROBIN [DE] C12Q1/6851 08-01 (+1)
56
TABLAS DE CONTENIDO
Revista Vaccine
New Articles in Press, 3 February-9 February 2014.
1. Association of the use of MMRV in infants by pediatric infectious disease specialists with that of other affiliated providers Original Research Article
Available online 7 February 2014 Bradley K. Ackerson, Bonnie H. Li, Lina S. Sy, Craig T. Cheetham, Steven J. Jacobsen
2. Methodological quality of systematic reviews on influenza vaccination Original Research Article
Available online 7 February 2014 Cornelius Remschmidt, Ole Wichmann, Thomas Harder
3. Effectiveness of slow-release systems in CD40 agonistic antibody immunotherapy of cancer Original Research Article
Available online 7 February 2014 Marieke F. Fransen, Robert A. Cordfunke, Marjolein Sluijter, Mies J. van Steenbergen, Jan W. Drijfhout, Ferry Ossendorp, Wim E. Hennink, Cornelis J.M. Melief
4. Biodistribution and lymph node retention of polysaccharide-based immunostimulating nanocapsules Original Research Article
Available online 7 February 2014 Sara Vicente, Beth A. Goins, Alejandro Sanchez, María J. Alonso, William T. Phillips
5. Seroprevalence of rubella antibodies in The Netherlands after 32 years of high vaccination coverage Original Research Article
Available online 7 February 2014 Gaby Smits, Liesbeth Mollema, Susan Hahné, Hester de Melker, Irina Tcherniaeva, Fiona van der Klis, Guy Berbers
6. Model based estimates of long-term persistence of inactivated hepatitis A vaccine-induced antibodies in adults Original Research Article
Available online 7 February 2014 Niel Hens, Aklilu Habteab Ghebretinsae, Karin Hardt, Pierre Van Damme, Koen Van Herck
7. The link between genetic variation and variability in vaccine responses: Systematic review and meta-analyses Original Research Article
57
Available online 7 February 2014 Brunella Posteraro, Roberta Pastorino, Paolo Di Giannantonio, Carolina Ianuale, Rosarita Amore, Walter Ricciardi, Stefania Boccia
8. Vaccination with a piggyBac plasmid with transgene integration potential leads to sustained antigen expression and CD8+ T cell responses Original Research Article
Available online 7 February 2014 Pietro Bertino, Johann Urschitz, FuKun W. Hoffmann, Bo Ra You, Aaron H. Rose, Woo Hyun Park, Stefan Moisyadi, Peter R. Hoffmann
9. Safety and serological response to a matrix gene-deleted rabies virus-based vaccine vector in dogs Original Research Article
Available online 7 February 2014 James P. McGettigan, Frederic David, Monica Dias Figueiredo, Jules Minke, Teshome Mebatsion, Matthias J. Schnell
10. Disorganized muscle protein-1 (DIM-1) of filarial parasite Brugia malayi: cDNA cloning, expression, purification, structural modeling and its potential as vaccine candidate for human filarial infection Original Research Article
Available online 7 February 2014 Vikas Kushwaha, Vikash Kumar, Shiv K. Verma, Rolee Sharma, M.I. Siddiqi, P.K. Murthy
11. Evaluation of the immunogenicity and safety of Brucella melitensis B115 vaccination in pregnant sheep Original Research Article
Available online 7 February 2014 Marta Pérez-Sancho, Rosanna Adone, Teresa García-Seco, Michaela Tarantino, Alberto Diez-Guerrier, Rosanna Drumo, Massimiliano Francia, Lucas Domínguez, Paolo Pasquali, Julio Álvarez
12. Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumonia Original Research Article
Available online 7 February 2014 Chamira Rodrigo, Thomas Bewick, Carmen Sheppard, Sonia Greenwood, Caroline Trotter, Mary Slack, Robert George, Wei Shen Lim
13. Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: A phase II, randomized, controlled study Original Research Article
Available online 6 February 2014 Roman Chlibek, Jan Smetana, Karlis Pauksens, Lars Rombo, J. Anneke R. Van den Hoek, Jan H. Richardus, Georg Plassmann, Tino F. Schwarz, Edouard Ledent, Thomas C. Heineman
14. Immunization with a DNA adenine methylase over-producing Yersinia
58
pseudotuberculosis vaccine confers robust cross-protection against heterologous pathogenic serotypes Original Research Article
Available online 6 February 2014 Jessica Z. Kubicek-Sutherland, Douglas M. Heithoff, Selvi C. Ersoy, William R. Shimp, Michael J. Mahan
15. Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: A case–control study Original Research Article
Available online 5 February 2014 Maria Y.T. Ichihara, Laura C. Rodrigues, Carlos A.S. Teles Santos, Maria da Gloria L.C. Teixeira, Sandra R. De Jesus, Sheila M. Alvim De Matos, Jose P. Gagliardi Leite, Mauricio L. Barreto
16. Safety of Japanese encephalitis live attenuated vaccination in post- marketing surveillance in Guangdong, China, 2005–2012 Original Research Article
Available online 4 February 2014 Yu Liu, Hualiang Lin, Qi Zhu, Chenggang Wu, Zhanjie Zhao, Huizhen Zheng
17. Vaccinations among medical and nursing students: Coverage and opportunities Original Research Article
Available online 4 February 2014 Pierre Loulergue, Odile Launay
18. Costs of vaccine delivery in the Gambia before and after, pentavalent and pneumococcal conjugate vaccine introductions Original Research Article
Available online 3 February 2014 E. Usuf, G. Mackenzie, Y. Lowe-Jallow, B. Boye, D. Atherly, C. Suraratdecha, U.K. Griffiths
59